Violence-related distress and lung function in two longitudinal studies of youth.
Gaietto, K; Han, YY; Forno, E; Bacharier, LB; Phipatanakul, W; Guilbert, TW; Cabana, MD; Ross, K; Blatter, J; Acosta-Pérez, E; et al.
European Respiratory Journal.
2022;
59.
Treatment by biomarker-informed endotype vs guideline care in children with difficult-to-treat asthma.
Guilbert, TW; Biagini, JM; Ramsey, RR; Keidel, K; Curtsinger, K; Kroner, JW; Durrani, SR; Stevens, M; Pilipenko, V; Martin, LJ; et al.
Annals of Allergy, Asthma and Immunology.
2022;
128:535-543.e6.
An International, Retrospective Study of Off-Label Biologic Use in the Treatment of Hypereosinophilic Syndromes.
Chen, MM; Roufosse, F; Wang, SA; Verstovsek, S; Durrani, SR; Rothenberg, ME; Pongdee, T; Butterfield, J; Lax, T; Wechsler, ME; et al.
Journal of Allergy and Clinical Immunology: In Practice.
2022;
10:1217-1228.e3.
Severe topical corticosteroid withdrawal syndrome or enigmatic drug eruption?.
Tracy, A; Durrani, S; Mir, A.
Journal of Allergy and Clinical Immunology: In Practice.
2022;
10:1125-1126.
Effect of vitamin D supplementation on total and allergen-specific IgE in children with asthma and low vitamin D levels.
Rosser, FJ; Han, YY; Forno, E; Bacharier, LB; Phipatanakul, W; Guilbert, TW; Cabana, MD; Ross, K; Blatter, J; Durrani, S; et al.
Journal of Allergy and Clinical Immunology.
2022;
149:440-444.e2.
Evaluation of Risk Scores to Predict Pediatric Severe Asthma Exacerbations.
Niu, C; Xu, Y; Schuler, CL; Gu, L; Arora, K; Huang, Y; Naren, AP; Durrani, SR; Hossain, MM; Guilbert, TW.
Journal of Allergy and Clinical Immunology: In Practice.
2021;
9:4393-4401.e8.
Vitamin D supplementation, lung function and asthma control in children with asthma and low vitamin D levels.
Han, YY; Forno, E; Bacharier, LB; Phipatanakul, W; Guilbert, TW; Cabana, MD; Ross, K; Blatter, J; Rosser, FJ; Durrani, S; et al.
European Respiratory Journal.
2021;
58.
Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels: the VDKA randomized clinical trial.
Forno, E; Bacharier, LB; Phipatanakul, W; Guilbert, TW; Cabana, MD; Ross, K; Covar, R; Gern, JE; Rosser, FJ; Blatter, J; et al.
2021.
Preventing asthma in high risk kids (PARK) with omalizumab: Design, rationale, methods, lessons learned and adaptation.
Phipatanakul, W; Mauger, DT; Guilbert, TW; Bacharier, LB; Durrani, S; Jackson, DJ; Martinez, FD; Fitzpatrick, AM; Cunningham, A; Kunselman, S; et al.
Controlled Clinical Trials.
2021;
100.
Anti-Siglec-8 Antibody for Eosinophilic Gastritis and Duodenitis.
Dellon, ES; Peterson, KA; Murray, JA; Falk, GW; Gonsalves, N; Chehade, M; Genta, RM; Leung, J; Khoury, P; Klion, AD; et al.
New England Journal of Medicine.
2020;
383:1624-1634.